Mark Muscat
- Epidemiology top 5%
- Health top 1%
- Infectious Diseases top 10%
- Immunology
- Applied Microbiology and Biotechnology top 1%
- Co-authors
- S GlismannHenrik BangDominique L. MonnetKåre MølbakJan WohlfahrtDragan JankovićRobb ButlerMyriam Ben Mamou
- Topics
- Virology and Viral Diseases (26 papers)Vaccine Coverage and Hesitancy (20 papers)Immune responses and vaccinations (11 papers)
In The Last Decade
Mark Muscat
37 papers receiving 966 citations
Peers
Comparison fields: 5 of 108
- Epidemiology 714
- Health 455
- Infectious Diseases 194
- Immunology 174
- Applied Microbiology and Biotechnology 128
Countries citing papers authored by Mark Muscat
This map shows the geographic impact of Mark Muscat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Muscat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Muscat more than expected).
Fields of papers citing papers by Mark Muscat
This network shows the impact of papers produced by Mark Muscat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Muscat. The network helps show where Mark Muscat may publish in the future.
Co-authorship network of co-authors of Mark Muscat
This figure shows the co-authorship network connecting the top 25 collaborators of Mark Muscat. A scholar is included among the top collaborators of Mark Muscat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Muscat. Mark Muscat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 5 | |
| 4 | 20 | |
| 5 | 54 | |
| 6 | 37 | |
| 7 | 73 | |
| 8 | 18 | |
| 9 | 16 | |
| 10 | 123 | |
| 11 | 8 | |
| 12 | 143 | |
| 13 | 7 | |
| 14 | 9 | |
| 15 | 9 | |
| 16 | 7 | |
| 17 | 41 | |
| 18 | 82 | |
| 19 | 1 | |
| 20 | 4 |
About Mark Muscat
Mark Muscat is a scholar working on Health, Applied Microbiology and Biotechnology and Epidemiology, having authored 39 papers that have together received 1.0k indexed citations. Recurring topics across this work include Virology and Viral Diseases (26 papers), Vaccine Coverage and Hesitancy (20 papers) and Immune responses and vaccinations (11 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (128 citations), Health (455 citations) and Epidemiology (714 citations). Mark Muscat has collaborated with scholars based in Denmark, Sweden and Malta. Frequent co-authors include S Glismann, Henrik Bang, Dominique L. Monnet, Kåre Mølbak, Jan Wohlfahrt, Dragan Janković, Robb Butler, Myriam Ben Mamou, Siddhartha Sankar Datta and Patrick O’Connor. Their work appears in journals such as The Lancet, The Journal of Infectious Diseases and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.